UnitedHealth Group Incorporated $UNH Stock Holdings Lessened by Aurdan Capital Management LLC

Aurdan Capital Management LLC reduced its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 8.2% during the second quarter, according to the company in its most recent filing with the SEC. The fund owned 15,846 shares of the healthcare conglomerate’s stock after selling 1,424 shares during the quarter. UnitedHealth Group makes up 1.7% of Aurdan Capital Management LLC’s portfolio, making the stock its 15th biggest position. Aurdan Capital Management LLC’s holdings in UnitedHealth Group were worth $4,943,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. iA Global Asset Management Inc. increased its position in UnitedHealth Group by 65.6% in the 2nd quarter. iA Global Asset Management Inc. now owns 373,821 shares of the healthcare conglomerate’s stock valued at $116,621,000 after acquiring an additional 148,097 shares during the period. Tredje AP fonden raised its stake in shares of UnitedHealth Group by 37.1% during the second quarter. Tredje AP fonden now owns 348,834 shares of the healthcare conglomerate’s stock valued at $108,826,000 after purchasing an additional 94,380 shares in the last quarter. TIAA Trust National Association grew its position in UnitedHealth Group by 32.7% in the 2nd quarter. TIAA Trust National Association now owns 189,214 shares of the healthcare conglomerate’s stock valued at $59,029,000 after buying an additional 46,629 shares in the last quarter. Harel Insurance Investments & Financial Services Ltd. lifted its stake in shares of UnitedHealth Group by 360.8% in the 2nd quarter. Harel Insurance Investments & Financial Services Ltd. now owns 3,737 shares of the healthcare conglomerate’s stock worth $1,166,000 after acquiring an additional 2,926 shares during the period. Finally, Jessup Wealth Management Inc lifted its stake in shares of UnitedHealth Group by 1.6% in the 2nd quarter. Jessup Wealth Management Inc now owns 6,449 shares of the healthcare conglomerate’s stock worth $2,012,000 after acquiring an additional 99 shares during the period. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of analysts have recently weighed in on UNH shares. Piper Sandler reduced their price target on shares of UnitedHealth Group from $423.00 to $417.00 and set an “overweight” rating for the company in a research note on Tuesday. Zacks Research raised shares of UnitedHealth Group from a “strong sell” rating to a “hold” rating in a research note on Monday, October 6th. Baird R W cut shares of UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research note on Thursday, July 31st. Jefferies Financial Group increased their target price on shares of UnitedHealth Group from $317.00 to $409.00 and gave the company a “buy” rating in a research note on Friday, October 17th. Finally, TD Cowen increased their target price on shares of UnitedHealth Group from $335.00 to $338.00 and gave the company a “hold” rating in a research note on Thursday. Eighteen equities research analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat, UnitedHealth Group has an average rating of “Moderate Buy” and an average price target of $397.12.

UnitedHealth Group Stock Down 1.0%

UNH stock opened at $341.46 on Friday. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73. The company’s 50 day simple moving average is $343.51 and its 200-day simple moving average is $327.62. The company has a debt-to-equity ratio of 0.71, a current ratio of 0.82 and a quick ratio of 0.85. The firm has a market capitalization of $309.25 billion, a P/E ratio of 17.82, a P/E/G ratio of 2.28 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.87 by $0.05. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The business had revenue of $113.16 billion for the quarter, compared to analyst estimates of $113.19 billion. During the same quarter in the previous year, the business earned $7.15 earnings per share. The firm’s revenue was up 12.2% compared to the same quarter last year. As a group, equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were issued a dividend of $2.21 per share. The ex-dividend date was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.6%. UnitedHealth Group’s payout ratio is currently 46.14%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.